login
login
Image header Agence Europe
Europe Daily Bulletin No. 13044
Contents Publication in full By article 30 / 33
NEWS BRIEFS / Health

EMA recommends authorisation of a tetravalent dengue vaccine in EU and worldwide

17/10/2022 (Agence Europe)On 13 October, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for the authorisation of the live inactivated tetravalent vaccine developed by the Japanese pharmaceutical company Takeda Pharmaceutical to prevent the disease caused by serotypes 1, 2, 3 and 4 of the dengue virus. The vaccine can be given from the age of 4 years. The EMA states that, for the first time, the CHMP is...

Contents

SECTORAL POLICIES
Russian invasion of Ukraine
EXTERNAL ACTION
INSTITUTIONAL
SOCIAL AFFAIRS
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
NEWS BRIEFS
Kiosk